SEC Form 4 · accession 0001683168-18-000919
International Stem Cell CORP · ISCO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Wright Don
Director
Period of report
Mar 30, 2018
Accepted (ET)
Apr 3, 2018 · 6:37 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001355790
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $1.47 | Mar 30, 2018 | A | 11,054 | A | — | Mar 30, 2028 | Common Stock | 11,054 | 11,054 | D |
Explanation of responses
- F1Stock option granted as part of compensation for non-employee directors. Options vest fully at time of grant. Q1 2018.